🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 10 of 15

  1. US 9309232

    Synthesis of novel inhibitors of isoprenoid biosynthesis

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9278942

    Non-steroidal compounds as androgen receptor modulators

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9249473

    Compositions and methods for the identification of inhibitors of retroviral infection

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9242937

    Pharmaceutically active disubstituted pyridine derivatives

    Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9238153

    Transoral methods and compositions for wrinkle reduction and cosmetic lip and facial augmentation

    Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9233940

    Cyclic peptidomimetic compounds as immunomodulators

    Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9227995

    Peptides

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9221838

    Inhibitors of AKT activity

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9221840

    Treating protein folding disorders with small molecule CFTR correctors

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9221843

    Heteroaryl inhibitors of PDE4

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9180161

    CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

    Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9173886

    Antiviral compounds and methods of use thereof

    Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9169280

    Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9156853

    AKT inhibitor compounds for treatment of cancer

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9138386

    Dental whitening compositions

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9133127

    Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

    Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9096642

    Therapeutic compounds for immunomodulation

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9096608

    Pharmaceutically active pyrazolo-triazine derivatives

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9062002

    Substituted pyridine derivatives as FabI inhibitors

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9062007

    Cyclic amide BACE-1 inhibitors having a benzamide substituent

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9062075

    Tetrahydropyridine derivatives as FabI inhibitors

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9056847

    Activity based probes (ABPs) interacting with glycosidases

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9051312

    Methods of treating dyskinesia and related disorders

    Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9044442

    Peptidomimetic compounds as immunomodulators

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9034923

    Methods for the treatment of senile dementia of the alzheimer's type

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8999982

    Pharmaceutically active compounds as Axl inhibitors

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8993623

    Method for lowering cholesterol

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8986005

    Strip for transferring a therapeutic composition to a tooth

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8981057

    B-cell stimulating fusion proteins of an antigen with BAFF or APRIL

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8962637

    Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8937093

    Heterocyclic aspartyl protease inhibitors

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8937178

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8907053

    Immunosuppression modulating compounds

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8865723

    Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury

    Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8853252

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8828977

    Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8778633

    Transcription factor modulator

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8778980

    Heterocyclic aspartyl protease inhibitors

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8771665

    Inhibitors of hepatitis C virus polymerase

    Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8748396

    Lyophilization of synthetic liposomal pulmonary surfactant

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8748397

    Lyophilization of synthetic liposomal pulmonary surfactant

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8729081

    Compositions and methods for treating alcohol use disorders, pain and other diseases

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8722708

    Substituted isoindolines as aspartyl protease inhibitors

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8716265

    4-quinolinemethanols as anti-malarial agents

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8716294

    Methods for treating inflammatory conditions

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8697387

    Methods for identifying agents and their use for the prevention of restenosis

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8691831

    Heterocyclic aspartyl protease inhibitors

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8680131

    Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.